Results from the first ever randomized controlled trial of its kind shows that providing older people at risk of dementia with healthy eating assistance, brain training, exercise, and management of metabolic and vascular risk factors slows down cognitive decline. The study, entitled the Finnish Geriatric Intervention Study…
According to a recent study conducted by a researcher from the University of Eastern Finland, the cognitive functioning of patients with Alzheimer’s disease and their behavioral and psychological difficulties are associated with their daily living activities. However, the researchers found that deficits in cognitive performance were not associated…
According to a recent study from researchers at the Keck School of Medicine of the University of Southern California, reduced expression of a protein called GLUT1, responsible for moving glucose in the brain-blood barrier (BBB) worsens Alzheimer’s disease cerebrovascular degeneration, neuropathology and cognitive function, suggesting that GLUT1 may represent…
The documentary “Looks Like Laury, Sounds Like Laury,” which tells the story of a woman fighting Frontotemporal Dementia, will premiere on American television next Tuesday, March 10th at 8 pm on the World Channel. The film produced by Pamela Hogan and Connie Shulman will be broadcasted as part of the third…
The Irish subsidiary of biopharmaceutical company Transition Therapeutics Inc. has finished patient enrollment for its phase 2 clinical study to assess a novel therapy for mild, moderate and severe Alzheimer’s disease. Transition Therapeutics Ireland Limited (TTIL) will now evaluate the neuropsychiatric drug candidate ELND005, expecting it…
According to medical specialists, research published last year stating that Vitamin B does not prevent Alzheimer’s disease is misleading, causing patients in early stages of the disease to miss out a potentially valuable treatment. Expert researchers and clinicians strongly criticized the previous study, saying that it is “inaccurate and misleading,” and are…
Researchers at the Uppsala University in Sweden recently found a molecular link between Type 2 Diabetes and Alzheimer’s disease based on a rare condition called amyloidosis that occurs in both conditions. The study is published in the American Journal of Pathology. Amyloidosis results from the accumulation of inappropriately…
Researchers at the Sunnybrook Research Institute in Toronto were able to reverse Alzheimer’s disease symptoms in mice with magnetic resonance (MR) imaging-guided focused ultrasound. Recent evidence has shown that MR imaging-guided focused ultrasound can briefly open the blood-brain barrier, allowing for an efficient transport of drugs…
A research team from the Karolinska Institutet in Sweden tested a new therapy for Alzheimer’s disease whereby patients received an implantable therapy that encourages the growth of a specific type of nerve cell that helps prevent the degradation of neurons. Alzheimer’s disease is driven by an early breakdown of…
A recent study found that preparing foods at high temperatures might increase the risk of Alzheimer’s disease. The results were published in the current issue of the Journal of Alzheimer’s Disease. The research team from The Icahn School of Medicine at Mount Sinai examined studies that assessed…
Get regular updates to your inbox.